NEONeoGenomics, Inc.
$16.58+61% 1Y
$16.58
$7.1952 weeks$19.90
Is the price fair?
What NEO's price assumes
NeoGenomics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 2.78× revenue.
2.78
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.71
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 3.08
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 2.71
- EV / EBIToperating margin −8.9%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 3.08
- Market capitalisation128.5 million shares, counted Jul 24, 2026
- $2.13B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Diagnostics & Research
Ranks #15 of 21 by RyuScore